Pharma News

Review of China's top ten key pharmaceutical regulations and policies in 2022

2023-01-26: https: www.cphi.cn. 2023-01-26. 13: 42. Source: CPHI Pharmaceutical Online. Author: Dishui Sinan For the pharmaceutical industry, this year is a year of comprehensive upgrading of China's drug regulatory system, NMPA and other regulatory authorities revised, introduced many heavy new regulations,  

 
CPHI 12 hours ago 5 minutes read

 
Xiaofeng: In the Year of the Rabbit, live an elegant life, do you still need a daily limit? All living medicine? Hanyu Pharmaceutical?


EASTMONEY 14 hours ago 3 minutes read

 
"Pharmaceutical Speed Reading Society" Bayer and Nektar Inhaled Antibiotic Amikacin Phase III Clinical Failure

2023-01-26: Nov 27, 2017. /. Pharmaceutical information list Ping An good doctor proposed to raise $1 billion in IPO; published the results of the second phase III clinical study of LMTX. (R); Ms. Gratile Acetate can fight multiple drug-resistant bacteria; Ethan Smart received 55 million yuan in round A funding...  

 
WUHANTY 18 hours ago 2 minutes read

 
Sihuan Pharmaceutical: Two non-PVC powder-liquid double-chamber bags have been included in the 2022 National Medical Insurance Catalog

2023-01-26: Original title: Sihuan Medicine: Two non-PVC powder double chamber bags were included in the 2022 National Medical Insurance Catalogue On January 26, 2023, Sihuan Pharmaceutical (00460.HK) announced that two first and exclusive products jointly developed by Sihuan Pharmaceutical (00460.HK) and its  

 
SOHU 18 hours ago 1 minute read

 
Zhongsheng Pharmaceutical: The company's non-public offering of A shares still needs to be approved by the China Securities Regulatory Commission. The company is concentrating on promoting the phase III clinical research of RAY1216 tablets

2023-01-26: On January 24, Zhongsheng Pharmaceutical said on the interactive platform that the company is continuing to promote the non-public offering of A-shares. The company has received the Notice of Second Feedback Opinions on the Review of Administrative Licensing Projects by the China Securities Regulatory  

 
EASTMONEY 20 hours ago 1 minute read

 
Pfizer Announces Covid Vaccine Development Progress. The mRNA Vaccine Is Expected to Enter Clinical Trials by the End of April

2023-01-26: On April 10, Pfizer announced significant progress in global research into novel coronavirus disease (COVID-19). Since the COVID-19 outbreak, the company has been working with many partners in the healthcare innovation ecosystem to address the global healthcare crisis posed by COVID-19. In a press release  

 
WUHANTY 21 hours ago 1 minute read

 
New technique used to identify culprits that trigger heart attacks

2023-01-26: Recently, researchers at the University of Manchester and the University of Hull developed a new method to identify irregular electrical "storm waves" in the heart. The related research, published in the international journal Computational Biology at the Public Library of Science, may help later researchers  

 
WUHANTY 1 day ago 1 minute read

 
It is time to cure the "distortionally high sales expenses" in pharmaceutical companies!

2023-01-25: Some time ago, a news that the Ministry of Finance carried out the quality inspection of accounting information in the pharmaceutical industry in 2019 caused an uproar in the pharmaceutical industry and led to a sharp fall in capital market pharmaceutical sector stocks. According to media reports, sales  

 
WUHANTY 1 day ago 3 minutes read

 
New developments in EZH2 inhibitors: two types have been approved, and Hengrui Medicine's SHR2554 has been included in the breakthrough treatment category

2023-01-25: https: www.cphi.cn. 2023-01-25. 14: 19. Source: CPHI Pharmaceutical Online. Author: Yi Yi Overall, EZH2 inhibitors are mostly in the early stages of development. China's pharmaceutical companies are also active in the layout of this field, such as Hengrui Pharmaceutical, Sinovii, Haihe Pharmaceutical.  

 
CPHI 1 day ago 2 minutes read

 
Delaying the new drug listing application for fixed increase? Response from Zhongsheng Pharmaceutical: Nonexistent

2023-01-25: Read Chuang / Shenzhen Business Daily reporter Ma Qiang The Chinese New Year holiday is a rare leisure and entertainment time for Chinese people, but the reporter noticed that on the interactive platform "Interactive Easy" of the Shenzhen Stock Exchange, in response to many investors' questions about

 
FINANCE.EASTMONEY 1 day ago 2 minutes read

 
Three Key Challenges of Integrative Medicine in Pediatrics

2023-01-25: On the face of it, it is very cost-effective for users to buy integrated pediatric health care products and get high-quality private pediatric services. Outpatient visits are guaranteed and the average price can be discounted. This is exactly what insurers expect when designing such integrated healthcare  

 
WUHANTY 1 day ago 1 minute read

 
Dextromethorphan Hydrobromide Oral Single Formulation Switched to Prescription Drugs - News - Tianya Pharmaceutical Network

2023-01-25: On December 27, the United States Food and Drug Administration announced that in order to ensure public drug safety, according to the "prescription drugs and over-the-counter drugs classification management method (trial)" (the former National Pharmaceutical Products Administration Order No. 10), approved  

 
WUHANTY 1 day ago 1 minute read

 
A list of the latest research progress in the field of brain cognition - News - Tianya Medicine

2023-01-25: I hope readers enjoy the latest research on brain cognition presented in this issue. 1. Sci.Signal: The Key to Neural Network Formation During Brain Development Recently, researchers from the Duquesas University School of Medicine discovered why brain cell connections are directed to differentiate  

 
WUHANTY 1 day ago 8 minutes read

 
Hainan will adjust the medical insurance catalog-News-Tianya Medicine

2023-01-25: On July 17, the Department of Human Resources and Social Security of Hainan Province publicly solicited comments on the "Hainan Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalogue (2017 Edition) Adjustment Work Plan (Draft for Solicitation of Comments)," and  

 
WUHANTY 2 days ago 2 minutes read

 
General Office of the State Council: The assessment of drug proportion and consumption proportion is gone! -News-Tianya Pharmaceutical Network

2023-01-24: Consumption ratio cancelled? On January 30, 2019, the General Office of the State Council issued Opinions on Strengthening the Performance Appraisal of Level III Public Hospitals, requiring that the first national level III public hospital performance appraisal be completed by the end of December  

 
WUHANTY 2 days ago 1 minute read

 
What development trends will the pharmaceutical industry present in 2023? Innovation, internationalization, etc. are key words


ZYZHAN 2 days ago 1 minute read

 
The employees of pharmaceutical production enterprises stick to their posts to ensure the supply of medicines

2023-01-24: CCTV News: This year's Spring Festival is China's first Spring Festival after the official implementation of the new coronavirus infection "type B ethyl tube." With the increase in demand for medical supplies, pharmaceutical manufacturers around the Spring Festival overtime to ensure the supply of drugs.  

 
NEWS.CCTV 2 days ago 1 minute read

 
Jacosi announced the completion of the first patient administration, and Aurora. A inhibitors are popular with capital

2023-01-24: https: www.cphi.cn. 2023-01-24. 11: 26. Source: CPHI Pharmaceutical Online. Author: Ye Fenghong Aurora. A, also known as Aurora kinase A, acts on both the MYC and Rb signaling pathways and is suitable for treating patients with Rb1 gene loss. Rb is a cancer suppressor gene equivalent to a "brake"  

 
CPHI 2 days ago 3 minutes read

 
Inventory of 13 black technologies. Let ALS, Parkinson, and dementia no longer be scary-News-Tianya Medicine

2023-01-24: Frozen people, Parkinson's disease and Alzheimer's disease have been the three major problems plaguing neurologists. It happens that all three diseases fall into one category and can be collectively referred to as neurodegenerative diseases. Not only is the disease incurable but it can get worse over

 
WUHANTY 2 days ago 4 minutes read

 
Ipratropium Bromide Ipratropium Bromide Inhalation Aerosol Generic Category 4 Listing Application Accepted-News-天ya Pharmaceutical Network

2023-01-23: Recently, according to the official website of CDE, isopropyl bromide inhalation aerosol of Sichuan Primate Pharmaceutical Co., Ltd. has been accepted for imitation class 4 listing application In 2019, sales of terminal isopropyl bromide inhalers in public medical institutions in China exceeded 1 billion  

 
WUHANTY 3 days ago 1 minute read

 

Load More



Trending in China

What China Reads


Pharma News


Review of China's top ten key pharmaceutical regulations and policies in 2022

2023-01-26: https: www.cphi.cn. 2023-01-26. 13: 42. Source: CPHI Pharmaceutical Online. Author: Dishui Sinan For the pharmaceutical industry, this year is a year of comprehensive upgrading of China's drug regulatory system, NMPA and other regulatory authorities revised, introduced many heavy new regulations,  


CPHI 12 hours ago 5 minutes read

 
Xiaofeng: In the Year of the Rabbit, live an elegant life, do you still need a daily limit? All living medicine? Hanyu Pharmaceutical?


EASTMONEY 14 hours ago 3 minutes read

 

"Pharmaceutical Speed Reading Society" Bayer and Nektar Inhaled Antibiotic Amikacin Phase III Clinical Failure

2023-01-26: Nov 27, 2017. /. Pharmaceutical information list Ping An good doctor proposed to raise $1 billion in IPO; published the results of the second phase III clinical study of LMTX. (R); Ms. Gratile Acetate can fight multiple drug-resistant bacteria; Ethan Smart received 55 million yuan in round A funding...  


WUHANTY 18 hours ago 2 minutes read

 

Sihuan Pharmaceutical: Two non-PVC powder-liquid double-chamber bags have been included in the 2022 National Medical Insurance Catalog

2023-01-26: Original title: Sihuan Medicine: Two non-PVC powder double chamber bags were included in the 2022 National Medical Insurance Catalogue On January 26, 2023, Sihuan Pharmaceutical (00460.HK) announced that two first and exclusive products jointly developed by Sihuan Pharmaceutical (00460.HK) and its  


SOHU 18 hours ago 1 minute read

 

Zhongsheng Pharmaceutical: The company's non-public offering of A shares still needs to be approved by the China Securities Regulatory Commission. The company is concentrating on promoting the phase III clinical research of RAY1216 tablets

2023-01-26: On January 24, Zhongsheng Pharmaceutical said on the interactive platform that the company is continuing to promote the non-public offering of A-shares. The company has received the Notice of Second Feedback Opinions on the Review of Administrative Licensing Projects by the China Securities Regulatory  


EASTMONEY 20 hours ago 1 minute read

 

Pfizer Announces Covid Vaccine Development Progress. The mRNA Vaccine Is Expected to Enter Clinical Trials by the End of April

2023-01-26: On April 10, Pfizer announced significant progress in global research into novel coronavirus disease (COVID-19). Since the COVID-19 outbreak, the company has been working with many partners in the healthcare innovation ecosystem to address the global healthcare crisis posed by COVID-19. In a press release  


WUHANTY 21 hours ago 1 minute read

 

New technique used to identify culprits that trigger heart attacks

2023-01-26: Recently, researchers at the University of Manchester and the University of Hull developed a new method to identify irregular electrical "storm waves" in the heart. The related research, published in the international journal Computational Biology at the Public Library of Science, may help later researchers  


WUHANTY 1 day ago 1 minute read

 

It is time to cure the "distortionally high sales expenses" in pharmaceutical companies!

2023-01-25: Some time ago, a news that the Ministry of Finance carried out the quality inspection of accounting information in the pharmaceutical industry in 2019 caused an uproar in the pharmaceutical industry and led to a sharp fall in capital market pharmaceutical sector stocks. According to media reports, sales  


WUHANTY 1 day ago 3 minutes read

 

New developments in EZH2 inhibitors: two types have been approved, and Hengrui Medicine's SHR2554 has been included in the breakthrough treatment category

2023-01-25: https: www.cphi.cn. 2023-01-25. 14: 19. Source: CPHI Pharmaceutical Online. Author: Yi Yi Overall, EZH2 inhibitors are mostly in the early stages of development. China's pharmaceutical companies are also active in the layout of this field, such as Hengrui Pharmaceutical, Sinovii, Haihe Pharmaceutical.  


CPHI 1 day ago 2 minutes read

 

Delaying the new drug listing application for fixed increase? Response from Zhongsheng Pharmaceutical: Nonexistent

2023-01-25: Read Chuang / Shenzhen Business Daily reporter Ma Qiang The Chinese New Year holiday is a rare leisure and entertainment time for Chinese people, but the reporter noticed that on the interactive platform "Interactive Easy" of the Shenzhen Stock Exchange, in response to many investors' questions about


FINANCE.EASTMONEY 1 day ago 2 minutes read

 

Three Key Challenges of Integrative Medicine in Pediatrics

2023-01-25: On the face of it, it is very cost-effective for users to buy integrated pediatric health care products and get high-quality private pediatric services. Outpatient visits are guaranteed and the average price can be discounted. This is exactly what insurers expect when designing such integrated healthcare  


WUHANTY 1 day ago 1 minute read

 

Dextromethorphan Hydrobromide Oral Single Formulation Switched to Prescription Drugs - News - Tianya Pharmaceutical Network

2023-01-25: On December 27, the United States Food and Drug Administration announced that in order to ensure public drug safety, according to the "prescription drugs and over-the-counter drugs classification management method (trial)" (the former National Pharmaceutical Products Administration Order No. 10), approved  


WUHANTY 1 day ago 1 minute read

 

A list of the latest research progress in the field of brain cognition - News - Tianya Medicine

2023-01-25: I hope readers enjoy the latest research on brain cognition presented in this issue. 1. Sci.Signal: The Key to Neural Network Formation During Brain Development Recently, researchers from the Duquesas University School of Medicine discovered why brain cell connections are directed to differentiate  


WUHANTY 1 day ago 8 minutes read

 

Hainan will adjust the medical insurance catalog-News-Tianya Medicine

2023-01-25: On July 17, the Department of Human Resources and Social Security of Hainan Province publicly solicited comments on the "Hainan Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalogue (2017 Edition) Adjustment Work Plan (Draft for Solicitation of Comments)," and  


WUHANTY 2 days ago 2 minutes read

 

General Office of the State Council: The assessment of drug proportion and consumption proportion is gone! -News-Tianya Pharmaceutical Network

2023-01-24: Consumption ratio cancelled? On January 30, 2019, the General Office of the State Council issued Opinions on Strengthening the Performance Appraisal of Level III Public Hospitals, requiring that the first national level III public hospital performance appraisal be completed by the end of December  


WUHANTY 2 days ago 1 minute read

 
What development trends will the pharmaceutical industry present in 2023? Innovation, internationalization, etc. are key words


ZYZHAN 2 days ago 1 minute read

 

The employees of pharmaceutical production enterprises stick to their posts to ensure the supply of medicines

2023-01-24: CCTV News: This year's Spring Festival is China's first Spring Festival after the official implementation of the new coronavirus infection "type B ethyl tube." With the increase in demand for medical supplies, pharmaceutical manufacturers around the Spring Festival overtime to ensure the supply of drugs.  


NEWS.CCTV 2 days ago 1 minute read

 

Jacosi announced the completion of the first patient administration, and Aurora. A inhibitors are popular with capital

2023-01-24: https: www.cphi.cn. 2023-01-24. 11: 26. Source: CPHI Pharmaceutical Online. Author: Ye Fenghong Aurora. A, also known as Aurora kinase A, acts on both the MYC and Rb signaling pathways and is suitable for treating patients with Rb1 gene loss. Rb is a cancer suppressor gene equivalent to a "brake"  


CPHI 2 days ago 3 minutes read

 

Inventory of 13 black technologies. Let ALS, Parkinson, and dementia no longer be scary-News-Tianya Medicine

2023-01-24: Frozen people, Parkinson's disease and Alzheimer's disease have been the three major problems plaguing neurologists. It happens that all three diseases fall into one category and can be collectively referred to as neurodegenerative diseases. Not only is the disease incurable but it can get worse over


WUHANTY 2 days ago 4 minutes read

 

Ipratropium Bromide Ipratropium Bromide Inhalation Aerosol Generic Category 4 Listing Application Accepted-News-天ya Pharmaceutical Network

2023-01-23: Recently, according to the official website of CDE, isopropyl bromide inhalation aerosol of Sichuan Primate Pharmaceutical Co., Ltd. has been accepted for imitation class 4 listing application In 2019, sales of terminal isopropyl bromide inhalers in public medical institutions in China exceeded 1 billion  


WUHANTY 3 days ago 1 minute read

 

Load More